학술논문

Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer
Document Type
Article
Source
In Clinical and Translational Radiation Oncology January 2024 44
Subject
Language
ISSN
2405-6308